GLP-1 analogue

DRUG2 trials

Sponsors

Tanabe Pharma Corporation, Kowa Company, Ltd.

Conditions

Type 2 Diabetes Mellitus

Phase 4

Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With GLP-1 Analogue in Patients With Type 2 Diabetes Mellitus

CompletedNCT02227849

Tanabe Pharma CorporationType 2 Diabetes Mellitus

Start: 2014-08-31End: 2016-03-31Updated: 2026-01-08

Tofogliflozin GLP-1 Analogue Combination Trial

CompletedNCT02537834

Kowa Company, Ltd.Type 2 Diabetes Mellitus

Start: 2015-08-31End: 2017-10-31Updated: 2020-11-17